Do diagnostic and treatment delays for colorectal cancer increase risk of death?

Cancer Causes and Control

Volumn 24, Issue 5, 2013, Pages 961-977

  Pruitt, Sandi L ^a,b   Harzke, Amy Jo ^c   Davidson, Nicholas O ^d,e   Schootman, Mario ^d,e  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d USA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Delayed diagnosis; Outcomes; SEER medicare; Survival; Time factors

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; SOCIAL STATUS; SURVIVAL TIME; THERAPY DELAY; TIME TO TREATMENT; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RISK ASSESSMENT; SEER PROGRAM; TIME FACTORS;

EID: 84892818493     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0172-6     Document Type: Article

References (60)

1. American Cancer Society Cancer Facts and Figures (2012) http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-031941.pdf. Accessed on 27 July 2012
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328(19):1365-1371
3. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653-657
4. Centers for Disease Control and Prevention (CDC) (2011) Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 60(26): 884-889
5. Neal RD (2009) Do diagnostic delays in cancer matter? Br J Cancer 101(Suppl 2):S9-S12
6. Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguilo A (2007) Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 43(17):2467-2478
7. Ramos M, Esteva M, Cabeza E, Llobera J, Ruiz A (2008) Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer 44(4):510-521
8. Terhaarsive Droste JS, Oort FA, van der Hulst RW, Coupe VM, Craanen ME, Meijer GA, Morsink LM, Visser O, van Wanrooij RL, Mulder CJ (2010) Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study. BMC Cancer 10:332
9. Fisher DA, Zullig LL, Grambow SC, Abbott DH, Sandler RS, Fletcher RH, El-Serag HB, Provenzale D (2010) Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci 55(5):1434-1441
10. Torring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P (2012) Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 65(6):669-678
11. Torring ML, Frydenberg M, Hansen RP, Olesen F, Hamilton W, Vedsted P (2011) Time to diagnosis and mortality in colorectal cancer: a cohort study in primary care. Br J Cancer 104(6):934-940
12. Iversen LH, Antonsen S, Laurberg S, Lautrup MD (2009) Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 96(10):1183-1189. doi:10.1002/bjs.6700
13. Jullumstro E, Lydersen S, Moller B, Dahl O, Edna TH (2009) Duration of symptoms, stage at diagnosis and relative survival in colon and rectal cancer. Eur J Cancer 45(13):2383-2390
14. Simunovic M, Rempel E, Theriault ME, Baxter NN, Virnig BA, Meropol NJ, Levine MN (2009) Influence of delays to nonemergent colon cancer surgery on operative mortality, diseasespecific survival and overall survival. Can J Surg 52(4):E79-E86
15. Wattacheril J, Kramer JR, Richardson P, Havemann BD, Green LK, Le A, El-Serag HB (2008) Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther 28(9): 1166-1174
16. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, Winchester DP, Bentrem DJ (2011) Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg 253(4):779-785
17. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8):IV-3-18
18. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BKe (eds)SEER cancer statistics review, 1975-2007, National Cancer Institute. Bethesda, MD. http://seer.cancer. gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010
19. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26(23):3860-3866
20. Coates AS (1999) Breast cancer: delays, dilemmas, and delusions. Lancet 353(9159):1112-1113
21. RichardsMA,Smith P,RamirezAJ, Fentiman IS,RubensRD(1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79(5-6): 858-864
22. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353(9159):1119-1126
23. Porter MP (2010) Examining the association between delay in diagnosis and decreased survival in bladder cancer. Cancer 116(22): 5122-5125
24. Ray WA (2005) Observational studies of drugs and mortality. N Engl J Med 353(22):2319-2321
25. Suissa S (2007) Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 16(3):241-249
26. Suissa S (2008) Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167(4):492-499
27. Jung SY, Sereika SM, Linkov F, Brufsky A, Weissfeld JL, Rosenzweig M (2011) The effect of delays in treatment for breast cancer metastasis on survival. Breast Cancer Res Treat 130(3):953-964
28. Hu C, Xing Y, Cormier JN, Chang GJ (2009) The validity of cause of death coding within the Surveillance, Epidemiology, and End Results (SEER) Registry. J Clin Oncol 27(15s):6544
29. Lund JL, Harlan LC, Yabroff KR, Warren JL (2010) Should cause of death from the death certificate be used to examine cancerspecific survival? A study of patients with distant stage disease. Cancer Invest 28(7):758-764
30. Maguire A, Porta M, Malats N, Gallen M, Pinol JL, Fernandez E (1994) Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer 30A(6):785-792
31. Taylor M, Turner D, Latosinsky S, Noseworthy T (2005) Determining acceptable waiting times for the surgical treatment of solid organ malignancies-A systematic review. http://www.cancercare.mb.ca/cancercare- resources/EPI/pdfs/CIHR-WaitTime-Report2-111005.pdf. Accessed 17 Nov 2011. Toward Canadian benchmarks for health services wait times? Evidence, application and research priorities (Report 2)
32. Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, Talley NJ, Vakil NB, Moayyedi P (2008) Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-Analysis. Gut 57(11):1545-1553
33. Jellema P, van der Windt DA, Bruinvels DJ, Mallen CD, van Weyenberg SJ, Mulder CJ, de Vet HC Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: systematic review and meta-Analysis. BMJ 340:c1269
34. El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G (2006) The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 166(20): 2202-2208
35. Fisher DA, Grubber JM, Castor JM Coffman CJ (2010) Ascertainment of colonoscopy indication using administrative data. Dig Dis Sci 55(6):1721-1725
36. American Medical Association (2001) Physicians' current procedural terminology CPT 2002. American Medical Association, Chicago
37. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML (2008) Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 100(12):888-897
38. Hodgson DC, Fuchs CS, Ayanian JZ (2001) Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93(7):501-515
39. Polite BN, Dignam JJ, Olopade OI (2006) Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24(14):2179-2187
40. Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF (2007) Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev 16(10):2118-2127
41. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383
42. National Cancer Institute SEER-Medicare: Calculation of comorbidity weights. http://healthservices.cancer.gov/seermedicare/program/comorbidity.html. Accessed on 18 July 2011
43. Parchman ML, Culler SD (1999) Preventable hospitalizations in primary care shortage areas. An analysis of vulnerable Medicare beneficiaries. Arch Fam Med 8(6):487-491
44. Iacus SM, King G, Porro G (2011) Multivariate matching methods that are monotonic imbalance bounding. Avail at http://gking. harvard.edu/files/abs/cem- math-Abs.shtml. J Am Stat Assoc 106: 345-361
45. Iacus SM, King G, Porro G (2011) Causal inference without balance checking: coarsened exact matching. Avail at http://gking.harvard.edu/files/abs/ cem-plus-Abs.shtml
46. Institute of Medicine Crossing the quality chasm: a new health system for the 21st century. National Academy Press, Washington, DC. Available at http://books.nap.edu/catalog.php?record-id=10027
47. Patwardhan MB, Samsa GP, McCrory DC, Fisher DA, Mantyh CR, Morse MA, Prosnitz RG, Cline KE, Gray RN (2006) Cancer care quality measures: diagnosis and treatment of colorectal cancer. Evidence report/technology assessment no. 138. (Prepared by the Duke Evidence based Practice Center under Contract No. 290-02-0025.) AHRQ Publication No. 06-E002. Agency for Healthcare Research and Quality, Rockville, MD
48. Department of Health (2000) Referral guidelines for suspected cancer. http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalas sets/@dh/@en/documents/ digitalasset/dh-4014421.pdf. Accessed 30 Nov 2011
49. Department of Health The NHS cancer plan. http://www.thh.nhs. uk/documents/-Departments/Cancer/NHSCancerPlan.pdf Accessed 29 Nov 2011
50. Korsgaard M, Pedersen L, Sorensen HT, Laurberg S (2006) Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis 8(8): 688-695
51. Singh H, De Coster C, Shu E, Fradette K, Latosinsky S, Pitz M, Cheang M, Turner D (2010) Wait times from presentation to treatment for colorectal cancer: a population-based study. Can J Gastroenterol 24 (1):33-39
52. Allgar VL, Neal RD (2005) Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: cancer. Br J Cancer 92(11):1959-1970
53. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112(2):594-642
54. Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361(25): 2449-2460
55. Porta M, Fernandez E, Alguacil J (2003) Semiology, proteomics, and the early detection of symptomatic cancer. J Clin Epidemiol 56(9):815-819
56. Singh H, Daci K, Petersen LA, Collins C, Petersen NJ, Shethia A, El-Serag HB (2009) Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol 104(10):2543-2554
57. McConnell YJ, Inglis K, Porter GA (2010) Timely access and quality of care in colorectal cancer: are they related? Int J Qual Health Care 22(3):219-228
58. Rai S,KellyMJ (2007) Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 9(3):195-202
59. Siminoff LA, Rogers HL, Thomson MD, Dumenci L, Harris-Haywood S (2011) Doctor, what's wrong with me? Factors that delay the diagnosis of colorectal cancer. Patient Educ Couns 84(3): 352-358
60. Hu CY, Delclos GL, Chan W, Du XL (2010) Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Med Oncol 28(4):1062-1074